PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients. (Q54287725)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients. |
scientific article |
Statements
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients (English)
Anne de la Rochefordiere
Maud Kamal
Anne Floquet
Laurence Thomas
Peter Petrow
Thierry Petit
Marius Pop
Michel Fabbro
Christine Kerr
Emmanuel Sevin
Sophie Maillard
Hervé Curé
Béatrice Weber
Claire Brunaud
Mathieu Minsat
Laurence Gonzague
Dominique Berton-Rigaud
Maud Aumont
Laurence Gladieff
Karine Peignaux
Virginie Bernard
Quentin Leroy
Audrey Margogne
AnaTereza Nadan
Virginie Fourchotte
Alhassane Diallo
Benard Asselain
Corine Plancher
Sébastien Armanet
Philippe Beuzeboc